Formulation of an anti-inflammatory drug using pH responsive poly(methacrylic acid)(PMAA)-graft-hollow silica for oral drug delivery
pH responsive properties of poly(methacrylic acid) (PMAA) grafted nano-sized hollow silica (PMAA-g-HSi) were characterized, and better formulation of sulfasalazine (an anti-inflammatory pro-drug used for bowel disease) was pursued using PMAA-g-HSi. To investigate pH responsive behaviour of PMAA-g...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/35521 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | pH responsive properties of poly(methacrylic acid) (PMAA) grafted nano-sized
hollow silica (PMAA-g-HSi) were characterized, and better formulation of
sulfasalazine (an anti-inflammatory pro-drug used for bowel disease) was pursued
using PMAA-g-HSi. To investigate pH responsive behaviour of PMAA-g-HSi,
fluorescein-isothiocyanate-dextran (FITC-dextran), was used a probe and the release
profile of FITC-dextran was monitored using fluorescence spectrometer. It was
found that FITC-dextran loaded into PMAA-g-HSi was retained in the PMAA-g-
HSi under acidic condition (pH2) for as long as 24h. However, FITC-dextran was
released in a single burst release when pH was increased to above 7. In order to get
better formulation of sulfasalazine with target delivery site at intestine (pH > 7) and
without drug loss and degradation at acidic stomach (pH <3), pH responsive PMAAg-
HSi was applied for encapsulation of sulfasalazine. Factors including drug
concentration, ultra-sonication time, and drug recycling, on the drug loading
capacity were investigated using UV spectroscopy. Also pH dependent release
profile of sulfasalazine from PMAA-g-HSi was monitored using UV spectroscopy.
It was shown that sulfasalazine was kept in PMAA-g-HSi at pH <2 but was released
out at pH > 7. So PMAA-g-HSi is promising for better formulation of sulfasalazine. |
---|